Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension

Ref ID 941
First Author R. Kanukula
Journal BMJ EVIDENCE-BASED MEDICINE
Year Of Publishing 2022
URL https://ebm.bmj.com/content/27/2/79.long
Keywords • Non-Cochrane reviews
• Low reporting quality
• Low methodological quality
• Cardiology
Problem(s) • Reasons for excluding potentially eligible studies not provided
• Risk of bias not incorporated into conclusions of review
• Low reporting (PRISMA) quality
• Low methodological (AMSTAR) quality
• No registered or published protocol
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country Australia
Checklists • AMSTAR 2
Aim To assess the methodological and reporting quality of systematic reviews that informed recommendations in the recent American and European hypertension guidelines published up to 2018.
Level of Investigation Descriptive
Summary of Findings From 40 included systematic reviews that informed recommendations in the recent American and European hypertension guidelines published up to 2018. Methodological (AMSTAR 2) and reporting (PRISMA) quality were found to vary considerably. Lack of information on the funding source of included studies, use of a protocol, integration of risk of bias assessments while interpreting findings and reporting of excluded studies were major methodological deficiencies.
Number of systematic reviews included 40
Number of eligible systematic reviews assessed 130
Treatment impacted No
Treatment impacted description
Interpretation impacted Not Applicable
Interpretation impacted description